Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular

Wenhua You1,2,3,4,5,6, Chupeng Hu2, Mengya Zhao2

  • 1School of Chemistry and Chemical Engineering, Center of Interventional Radiology and Vascular Surgery, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.

Gut
|September 12, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos